Dual Antiplatelet Therapy
Guanxinning tablet for patients who switch from dual antiplatelet therapy to aspirin alone after percutaneous coronary intervention: study protocol for a cluster randomized controlled trial
... with dual antiplatelet therapy (DAPT) for 12 months after PCI has been considered standard care for preventing stent thrombosis and major adverse cardiovascular events ...month therapy also ...
8
Unexpected Discontinuation of Dual Antiplatelet Therapy within 14 Days after Percutaneous Coronary Intervention: A Single-center Case Series
... antithrombotic therapy is associated with an increased risk of ...oral antiplatelet therapy, dual antiplatelet therapy (DAPT) is generally recommended by various guidelines for ...
9
Single and dual antiplatelet therapy in elderly patients of medically managed myocardial infarction
... Methods: This retrospective study identified very elderly (> 85 years) patients, who were medically managed, with their first AMI from the Taiwan National Health Insurance claims database from 2007 to 2010. Patients ...
8
Original Article Efficacy and safety of dabigatran and dual antiplatelet therapy after left atrial appendage occlusion with the Watchman device
... of dual antiplatelet therapy for 6 months, in patients with intolerance to oral anticoagulants after implantation of the Watchman occluder ...aspirin dual antiplatelet drugs for 4-6 ...
8
A Study on the Effectiveness of Mono and Dual Antiplatelet Therapy in Secondary Prevention of Vascular Events
... triple therapy group: Long term triple antiplatelet therapy was associated with a significant increase in adverse events and bleeding rates, and their severity, and a trend to increased ...term ...
93
Duration of dual antiplatelet therapy after coronary stent insertion
... DAPT—dual antiplatelet therapy, DES—drug-eluting stent, DES-LATE—Optimal Duration of Clopidogrel Therapy with DES to Reduce Late Coronary Arterial Thrombotic Event, G1DES—first-generation ...
7
Efficacy and safety of 12 versus 48 months of dual antiplatelet therapy after implantation of a drug eluting stent: the OPTImal DUAL antiplatelet therapy (OPTIDUAL) trial: study protocol for a randomized controlled trial
... optimal dual antiplatelet therapy (OPTIDUAL) study aims to compare the benefits and risks of dual antiplatelet therapy applied for either 12 or 48 ...with dual ...
6
Single versus Dual Antiplatelet Therapy after CABG Surgery
... optimal antiplatelet therapy regimen in the early post-operative CABG period is not well ...or dual antiplatelet therapy had better outcomes in those status-post CABG ...combination ...
5
Dual antiplatelet therapy for secondary prevention of coronary artery disease
... Dual antiplatelet therapy (DAPT) combining aspirin and a P2Y 12 receptor inhibitor has been consistently shown to reduce recurrent major adverse cardiovascular events (MACE) in patients with acute ...
16
Dual Antiplatelet Therapy in Cardiology: Novel Guidelines
... (PCI) dual antiplatelet therapy (DAPT) with the COX1/2 inhibitor aspirin and the P 2 Y 12 inhibitor clopidogrel was found to be more effective than oral anticoagulation (OAC) in reducing the risk of ...
11
The dogma of aspirin: a critical review of evidence on the best monotherapy after dual antiplatelet therapy
... 90s dual antiplatelet therapy based on the combination of an ADP-receptor antagonist plus as- pirin has been proposed to reach a more efficient inhib- ition of platelet function by simultaneously ...
5
Dual antiplatelet therapy up to the time of non-elective coronary artery bypass grafting with prophylactic platelet transfusion: is it safe?
... Background: Guidelines suggest that patients discontinue Clopidogrel at least 5 days prior to coronary artery bypass grafting (CABG). Those with acute coronary syndrome (ACS) are at high risk for myocardial infarction ...
7
Optimal duration of dual antiplatelet therapy after drug eluting stent implantation: a network meta-analysis
... of dual antiplatelet therapy (DAPT) after drug eluting stent (DES) implantation has remained in conten- tion, with the recently updated guidelines from major American cardiology societies ...
11
Individualising dual antiplatelet therapy after percutaneous coronary intervention: the IDEAL-PCI registry
... that dual HPR to ADP-induced as well as arachi- donic acid-induced (AA; re fl ecting response to ASA) aggregation, measured by multiple electrode aggrego- metry (MEA) 12 or the VerifyNow assay, 13 predisposes ...
10
The clinical outcomes of triple antiplatelet therapy versus dual antiplatelet therapy for high-risk patients after coronary stent implantation: a meta-analysis of 11 clinical trials and 9,553 patients
... “triple antiplatelet therapy”, “TAPT”, “dual anti- platelet therapy”, “DAPT”, “acute myocardial infarction or AMI”, “acute coronary syndrome or ACS”, “chronic total occlusion”, “left main”, ...
14
Dual antiplatelet therapy for secondary stroke prevention
... The antiplatelet selected for ongoing secondary prevention once DAPT is com- plete depends on which agent was used before the stroke or TIA; however, there is little evidence to guide step-down ...
6
Safety of tirofiban and dual antiplatelet therapy in treating intracranial aneurysms
... results of the studies of Liang and Kim, and our series, we recommend the following protocol for SAC or place- ment of a flow diverter in treating acutely ruptured intrac- ranial aneury[r] ...
7
Effects of Coronary Artery Revascularization with a Polymer Free Biolimus A9–Coated BioFreedom Stent Versus Bypass Surgery before Noncardiac Surgery
... in which urgent surgery is needed, such as cancer. With drug- eluting stents (DES), elective surgery is recommended to be delayed for >6 months upon their implantation. Polymer- and carrier-free Biolimus A9−coated ...
9
Characterisation of clot microstructure properties in stable coronary artery disease
... receiving antiplatelet therapy, 12% were receiving dual ...receiving dual antiplatelet therapy compared with no therapy ...that dual antiplatelet ...
8
Prasugrel Inappropriate Use in Patients Post-percutaneous coronary intervention (PCI). A Single Center Study
... The cornerstone in the management of acute coronary syndrome (ACS) is dual antiplatelet therapy (DAPT) including aspirin and P2Y12 inhibitors. 1 DAPT is most beneficial for patients undergoing ...
8